Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
Conclusion: Rechallenge was successful in most of our cohort. Pyrazinamide rechallenge should be carefully considered.
Source: Southern African Journal of HIV Medicine - Category: African Health Authors: Muhammed Shiraz Moosa Source Type: research
More News: Acetylcysteine | African Health | Liver | South Africa Health | Tuberculosis | Urology & Nephrology